Cerebrospinal Fluid Markers in Creutzfeldt-Jakob Disease
Author Information
Author(s): Anders Skinningsrud, Vidar Stenset, Astrid S Gundersen, Tormod Fladby
Primary Institution: Akershus University Hospital
Hypothesis
The study aims to assess the utility of total tau protein, the ratio of total tau to phosphorylated tau protein, and 14-3-3 protein as diagnostic markers in cerebrospinal fluid for Creutzfeldt-Jakob disease.
Conclusion
The results suggest that 14-3-3 protein may be the better marker for CJD, while the tTau/P-Tau ratio and tTau are also efficient markers but slightly inferior.
Supporting Evidence
- Total Tau, tTau/P-Tau ratio, and 14-3-3 protein are useful markers for diagnosing CJD.
- 14-3-3 protein may be slightly better than tTau/P-Tau for diagnosing CJD.
- Patients with CJD had higher levels of tTau compared to those with other neurological diseases.
- The study identified 12 cases of CJD in a population of about 4.5 million over two years.
Takeaway
Doctors can use certain proteins in spinal fluid to help diagnose a brain disease called Creutzfeldt-Jakob disease, and one of these proteins might be the best at doing that.
Methodology
CSF samples from patients with tTau values > 1200 ng/L were analyzed for total tau, phosphorylated tau, and 14-3-3 protein.
Potential Biases
There may be a risk of misclassification of CJD patients due to the low autopsy frequency.
Limitations
The study had a low frequency of histological verification and relied on clinical diagnosis.
Participant Demographics
Patients included 12 with CJD and others with Alzheimer's disease and other neurological diseases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website